Literature DB >> 17960495

Attitudes and perceptions of patients towards methods of establishing a DNA biobank.

Jill M Pulley1, Margaret M Brace, Gordon R Bernard, Dan R Masys.   

Abstract

BACKGROUND: This study aimed to assess patient attitudes as part of the planning process for a large-scale effort to collect genetic samples for research from excess clinical blood specimens ('DNA Databank' project).
METHOD: A pre-tested, 38-item questionnaire was mailed to a random sample of 5,000 inpatients, outpatients, and emergency department patients.
RESULTS: Approximately 20% of patients responded (n = 1003). Most were comfortable with anonymized genetic information being used for research (89.3%) and supported the potential benefits (98.7%). A binary logistic regression on the level of comfort with the DNA program shows that the variability in respondents' feelings about the program can best be explained by beliefs, age, and health status. Respondents were attitudinally segmented into 5 distinct categories.
CONCLUSIONS: These data indicate general acceptance among respondents, but a subset of the population would be opposed to the program. This reinforces the need to broadly and continuously communicate with patients about the program and the ability to exclude a given sample. The effects of prior beliefs would benefit from further exploration.

Entities:  

Mesh:

Year:  2007        PMID: 17960495     DOI: 10.1007/s10561-007-9051-2

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  50 in total

1.  Biobank Recruitment: Motivations for Nonparticipation.

Authors:  Katrina A B Goddard; K Sabina Smith; Chuhe Chen; Carmit McMullen; Cheryl Johnson
Journal:  Biopreserv Biobank       Date:  2009-06       Impact factor: 2.300

2.  Engaging African-Americans about biobanks and the return of research results.

Authors:  Colin Me Halverson; Lainie Friedman Ross
Journal:  J Community Genet       Date:  2012-03-28

3.  Hypothetical and factual willingness to participate in biobank research.

Authors:  Linus Johnsson; Gert Helgesson; Thorunn Rafnar; Ingibjorg Halldorsdottir; Kee-Seng Chia; Stefan Eriksson; Mats G Hansson
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

4.  Proven processes: The Vanderbilt Institute for clinical and translational research .

Authors:  Jill M Pulley; Gordon R Bernard
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

5.  Two large-scale surveys on community attitudes toward an opt-out biobank.

Authors:  Kyle B Brothers; Daniel R Morrison; Ellen W Clayton
Journal:  Am J Med Genet A       Date:  2011-11-07       Impact factor: 2.802

6.  Ethical and practical challenges to studying patients who opt out of large-scale biorepository research.

Authors:  S Trent Rosenbloom; Jennifer L Madison; Kyle B Brothers; Erica A Bowton; Ellen Wright Clayton; Bradley A Malin; Dan M Roden; Jill Pulley
Journal:  J Am Med Inform Assoc       Date:  2013-07-25       Impact factor: 4.497

7.  Public perspectives on biospecimen procurement: what biorepositories should consider.

Authors:  Jamie L'Heureux; Jeffrey C Murray; Elizabeth Newbury; Laura Shinkunas; Christian M Simon
Journal:  Biopreserv Biobank       Date:  2013-05-29       Impact factor: 2.300

8.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

9.  Public perspectives on informed consent for biobanking.

Authors:  Juli Murphy; Joan Scott; David Kaufman; Gail Geller; Lisa LeRoy; Kathy Hudson
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

10.  Biobanks and the phantom public.

Authors:  Herbert Gottweis; Haidan Chen; Johannes Starkbaum
Journal:  Hum Genet       Date:  2011-07-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.